Selling A Medical Practice (2026)

How much is your practice actually worth, and how long will it take to close a sale? Selling a medical practice in 2026 typically means a transaction value between 2x and 3x seller's discretionary earnings (SDE) for smaller practices, or 6x to 12x EBITDA for platform-sized practices, with deals closing in 6 to 12 months and most sellers receiving 60% to 70% of the purchase price at closing. The remainder comes through earnouts, seller notes, or rolled equity. Those are the headline ranges, and like all headline ranges they hide a lot of variation. The sections below walk through what drives your specific multiple, what buyers actually examine in due diligence, and how to structure the deal so the number on the wire matches the number on the term sheet.

What Medical Practices Are Selling For in 2026

BizBuySell's medical practice benchmarks track five years of closed transactions, and the trajectory is striking. Median sale price climbed from $347,500 in 2021 to $537,000 in 2025 - roughly 55% growth, about double the pace of the broader business-for-sale market. Median asking price across active 2026 listings sits closer to $750,000, with practices for sale ranging from under $350,000 for solo primary-care setups to over $1.5 million for multi-physician groups.

The trajectory hides wide variation underneath. BizBuySell's transaction database, which tracks where physicians and platforms buy and sell practices nationwide, shows medical practices trading between 1.46x and 2.94x SDE for the middle 50% of deals, with the average earnings multiple at 2.37x. Revenue multiples - applied to annual revenue rather than earnings - cluster between 0.42x and 0.91x, averaging 0.76x. Both ranges run lower than comparable service businesses outside healthcare, primarily because the buyer pool is narrower: only licensed physicians (or PE-backed platforms with licensed clinical leadership) can ultimately own and operate a medical practice in most states.

For larger practices, the math shifts. Sofera Advisors reports 2025-2026 EBITDA multiples of 6x to 8x for practices generating $500K to $1M in EBITDA, climbing to 10x to 12x for platforms above $5M EBITDA. FOCUS Investment Banking puts the median healthcare-services EV/EBITDA at 11.5x in 2025, down from 14.5x in 2024 - a moderation driven by higher borrowing costs and more selective buyers, not a structural shift in demand. PitchBook reported a 16.5% year-over-year decline in physician-practice deal count for Q1 2026 with a 23.3% drop in total PE deal value, though dental, dermatology, musculoskeletal, and vision held up better than the average.

The takeaway: there is no single "medical practice valuation multiple" worth quoting at a cocktail party. Where your practice valuation actually lands when selling a medical practice in this market depends on specialty, size, payor mix, growth trajectory, and how prepared you are when buyers start asking real questions.

How Buyers Calculate Medical Practice Valuation

When selling a medical practice, two questions decide your number: which cash flow metric is being multiplied, and what multiple does the buyer apply to it?

SDE versus EBITDA. For practices generating under roughly $1 million in true earnings, seller's discretionary earnings (SDE) is the standard metric. SDE adds back owner compensation, discretionary expenses, and non-recurring costs to produce the cash flow a single owner-operator could realistically extract. For larger practices - typically those with $1M-plus in normalized earnings - buyers move to EBITDA, which excludes owner compensation and treats the practice more like a financial asset than an owner-operator's job.

The metric choice is not cosmetic. A practice generating $800K in SDE might value at 2.5x for $2 million; the same operation presented as $700K in EBITDA at a 7x multiple lands at $4.9 million. Same business, different lens, very different price. Owners who let buyers default to SDE on a practice that has matured past that framing are leaving money on the table - sometimes seven figures of it. In Iconic's medical-practice engagements, this shift typically happens around the $1M normalized earnings threshold; below that, buyer pools default to SDE, and above it the conversation between buyer and seller moves to EBITDA whether sellers are ready or not.

Goodwill carries most of the value. Strategic Medical Brokers' analysis of healthcare-practice transactions finds that intangibles - patient relationships, staff continuity, referral networks, reputation, and covenants not to compete - represent 60% to 80% of total practice value in most deals. Equipment, leasehold improvements, and supplies are a rounding error in a typical medical or surgical practice transaction. As one Strategic Medical Brokers analysis puts it:

Goodwill encompasses the relationships and trust a seller has fostered with patients, staff, and the community. These bonds assure much of the revenue stream in a practice.

The split between personal goodwill (tied to the selling physician individually) and entity goodwill (tied to the practice as a unit including location, systems, staff, and records) is more than academic. Personal goodwill is harder to transfer and is typically taxed at capital gains rates when properly documented; entity goodwill transfers cleanly with the business. Federal healthcare law also restricts hospitals from paying for physician goodwill in certain arrangements, since it can read as compensation for referrals - a structural reason hospital buyers often pay less than PE platforms for the same practice.

Specialty drives the upper bound. FOCUS Investment Banking notes that cardiology and ophthalmology continue to command the highest valuations in medical practice transactions in 2026, with dermatology, orthopedics, gastroenterology, and behavioral health close behind. Sustained private equity competition - Sofera Advisors counted 79 physician-practice PE deals in Q1 2025 alone, and PE ownership of physician practices reached 6.5% of the market by late 2024 - keeps multiples elevated in these specialties even as broader healthcare deal volume cools. Primary care without ancillary revenue trades at the lower end of every range above. Compared with selling a manufacturing business in the same earnings tier, healthcare specialty bands swing more on payor mix and regulatory exposure than on operational sophistication.

Frequently Asked Questions

The questions about selling a medical practice that come up most often in early advisor conversations are not about valuation - they are about timing, structure, and what arrives in the seller's account at closing. These four address the issues that change deal economics most.

How long does it take to sell a medical practice?

The active transaction - from confidential marketing through closing - typically runs 6 to 12 months, with BizBuySell reporting a median 205 days on market for medical practices sold in 2025. Well-prepared, clean transactions can close in under 90 days; complex multi-location practices or deals with regulatory novation issues stretch to 12 to 18 months. The preparation phase before active marketing usually runs 18 to 24 months for non-retirement sales and 2 to 3 years for sellers timing a retirement exit (U.S. Bank Healthcare Banking, 2026).

Should I use an asset sale or entity sale structure?

Most medical practice transactions close as asset sales, where the buyer acquires specified tangible and intangible assets and assumes only specified liabilities; the structure determines exactly which assets or liabilities transfer at closing. Buyers prefer this because it limits inherited liability and produces a stepped-up basis for depreciation; sellers often pay ordinary income on equipment recapture and capital gains on goodwill. Entity (stock) sales transfer the legal entity itself, which is cleaner operationally but exposes the buyer to historical liabilities and typically requires a higher purchase price to compensate. The right answer depends on your entity type (S-corp, LLC, C-corp), payor contract novation requirements, and your tax basis - work this with your CPA before signing an LOI.

What percentage of sale proceeds do I receive at closing versus earnout?

VERTESS Healthcare Advisors reports a typical structure pays the seller 60% to 70% of the purchase price at closing, with the balance through some combination of earnout (tied to revenue retention or EBITDA performance over 2 to 5 years), seller note financing at a negotiated rate, or rolled equity in the acquiring platform. PE buyers in particular use rolled equity to keep buyer and seller aligned with the post-close performance the platform needs to monetize at its own exit.

What are the main factors buyers evaluate in due diligence?

Buyer due diligence typically runs 8 to 12 weeks after a letter of intent is signed and focuses on six areas: financial accuracy (clean accrual books, normalized earnings, documented add-backs), payor mix and contract assignability, compliance posture (coding, HIPAA, billing audits), employment agreements and key staff retention, real estate and equipment leases, and any open regulatory or licensure items. Sellers who organized this material with an accountant familiar with healthcare practice transactions move through diligence faster and lose less value to re-trade than those who scramble after the LOI.

The Sale Process and Timeline

The active transaction in selling a medical practice is shorter than the preparation that precedes it. U.S. Bank's healthcare practice sale guidance recommends starting preparation 2 to 3 years before a planned retirement sale; for non-retirement transitions, 18 to 24 months is typically enough. The marketing-to-close window then runs 6 to 12 months for most well-prepared practices.

Practice Transitions Group's framework splits the process into three phases:

1. Preparation and planning (18 months to 5 years pre-sale). Clean financials, normalize owner compensation, document procedures, address operational drag on margins, resolve any compliance or coding issues, and stabilize the staff. Practices that compress this phase pay for it later - either in a lower multiple or, more painfully, in a deal that falls apart in due diligence after months of work.
2. Marketing and negotiation (3 to 6 months). Confidential marketing through an advisor or broker, buyer outreach across the relevant pool (PE platforms, strategic groups, individual physicians, hospital systems), indication-of-interest gathering, valuation negotiation, and an executed letter of intent.
3. Due diligence and closing (8 to 12 weeks post-LOI). Buyer verification of financials, payor mix, compliance posture, and employment agreements; final negotiations; definitive agreement drafting; regulatory and licensure clearances; and closing.

BizBuySell's 2025 data shows a median 205 days on market for medical practices that ultimately sold, with the broader small-business market sitting at 170 days for comparison. Healthcare runs longer because the buyer pool is smaller and the regulatory layer is thicker.

Iconic's healthcare-practice advisory work typically begins in the preparation phase - 18 to 24 months out is the window in which financial cleanup and operational tightening can still materially move the eventual multiple. Beyond that horizon, the conversation shifts from "what can we improve" to "what is your practice today and how do we present it cleanly." Both conversations are worth having; they are not the same conversation.

Deal Structure and What You Actually Take Home

Most medical practice sales are not 100% cash at closing. VERTESS Healthcare Advisors reports the typical structure pays the seller 60% to 70% of the purchase price upfront, with the remainder coming through three common mechanisms:

• Earnout payments tied to revenue retention or EBITDA performance over 2 to 5 years post-close
• Seller note financing at a negotiated interest rate, paid over a defined term
• Rolled equity in the acquiring platform, particularly in PE recapitalizations where the platform is building toward its own exit

The asset-sale-versus-entity-sale decision drives both tax outcome and risk allocation. In an asset sale, the buyer and seller specify exactly which assets or liabilities transfer; the buyer assumes only those, and the seller generally pays capital gains on goodwill and ordinary income on equipment depreciation recapture. In an entity (stock) sale, the buyer acquires the legal entity itself, inheriting both assets and liabilities, while the seller typically gets capital gains treatment on the full transaction. Buyers prefer asset sales for the liability shield and stepped-up basis; sellers often prefer entity sales for the cleaner tax outcome and fewer novation steps on payor contracts.

The right structure depends on entity type, the assignability of your payor contracts, and whether the buyer can absorb legacy liabilities at the price they want to pay. The best possible outcome on net proceeds depends on getting this right - the wrong structure can shift the take-home number by 10% or more of the headline price. Work it out with your CPA and an M&A attorney before the LOI is signed; changing structure after that point is expensive and frequently triggers a re-trade with the buyer.

One more piece of the structure worth flagging: most sellers stay on as employees for 2 to 5 years post-close at market-rate compensation. That post-close transition employment is part of how buyers protect the goodwill they paid for, and it is also the period over which earnout performance is measured. If you are planning to retire fully on day one of the new owner's tenure, the deal structure that maximizes your check will likely look very different from the structure a buyer is willing to underwrite.

Where to Start

Selling a medical practice is a multi-year decision compressed into a 6-to-12-month execution window. The valuation work, financial cleanup, and operational tightening that drive your multiple happen long before any buyer sees a confidential information memorandum. The earlier you begin, the more options you preserve - on price, on buyer type, and on the structure of what you take home. Owners who delay until they are forced to choose between close or sell quickly at a discount lose those options entirely.

Three key tips for selling in 2026:

1. Get a defensible baseline valuation. Know your current SDE and EBITDA, your specialty-adjusted multiple range, and the gap between today's number and where the practice could trade after 18 to 24 months of preparation. A qualified business appraiser or experienced M&A advisor can produce that working number; Iconic offers a complimentary business valuation for owners exploring an exit, and the output is a planning baseline, not a pitch deck.
2. Audit your books through a buyer's lens. Clean accrual-basis financials, normalized owner compensation, documented add-backs, and clean payor-mix reporting are non-negotiable in due diligence. The practices that come through diligence without re-trades are the ones whose owners worked with an accountant familiar with healthcare M&A 18 months before listing, not the night before the data room opened. The point is to plan in advance to maximize what survives the buyer's scrutiny.
3. Talk to an advisor who has actually closed practice transactions. The buyer universe - PE platforms, hospital systems, larger group practices, individual physicians considering buying a practice - behaves very differently across specialties and deal sizes. Generic M&A advisors miss the regulatory and payor nuances that healthcare deals turn on; a specialist M&A banker can help frame your specialty-adjusted range and identify which buyer pool delivers the structure you want. For broader strategic preparation on any sale, our list of 10 must-read business books for selling covers the groundwork most owners skip.

Iconic has guided more than 200 business owners through the sale process. Whether you are buying or selling a business in healthcare, or weighing whether to buy or sell into a roll-up structure, the work happens long before the term sheet arrives. The best decision for owners 1 to 3 years out from a possible transition is to map what an exit would actually look like before the spreadsheet work begins - the first conversation is worth having now.